IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry
NCT ID: NCT04520347
Last Updated: 2025-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
10000 participants
OBSERVATIONAL
2018-12-01
2027-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ventricular Tachycardia Cohort
NCT07149701
Computational Cardiac Imaging Analysis to Guide Ventricular Tachycardia Ablation Procedures (AI-VT)
NCT06964152
Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia
NCT01426425
Brain Perfusion and Hemodynamic Stability in Patients Undergoing Radiofrequency Ablation of Ventricular Tachycardia
NCT01695551
Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators
NCT01557842
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this study is to create a prospective international database registry that will allow for better assessment of the outcomes of catheter ablation of ventricular arrhythmias. The registry, with approximately 30 participating centers, will help to identify the overall success rates and associated benefits of the procedure and provide more comprehensive data on understudied populations and treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jason Bradfield, MD
Director, Specialized Program for Ventricular Tachycardia
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jason Bradfield, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Kalyanam Shivkumar, MD, PhD
Role: STUDY_CHAIR
University of California, Los Angeles
Paolo Della Bella, MD
Role: STUDY_CHAIR
San Raffaele Hospital, Italy
Francis Marchlinski, MD, FACC, FAHA, FHRS
Role: STUDY_CHAIR
University of Pennsylvania Health System
Andrea Natale, MD, FACC, FHRS, FESC
Role: STUDY_CHAIR
Texas Cardiac Arrhythmia Institute at St. David's Medical Center
William G Stevenson, MD
Role: STUDY_CHAIR
Vanderbilt Heart and Vascular Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Banner Health, University of Arizona Medical Center
Phoenix, Arizona, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
University of California, Los Angeles
Los Angeles, California, United States
University of California, Davis
Sacramento, California, United States
University of California San Francisco
San Francisco, California, United States
University of Colorado Hospital
Aurora, Colorado, United States
Hartford HealthCare
Hartford, Connecticut, United States
University of Florida Health
Gainesville, Florida, United States
The Kansas City Heart Rhythm Institute
Kansas City, Kansas, United States
University of Maryland Medical Center
Baltimore, Maryland, United States
Johns Hopkins Heart and Vascular Institute
Baltimore, Maryland, United States
Boston Children's Hospital
Boston, Massachusetts, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
UMass Memorial Health Care
Worcester, Massachusetts, United States
University of Michigan Frankel Cardiovascular Center
Ann Arbor, Michigan, United States
University of Minnesota VA Medical Center
Minneapolis, Minnesota, United States
Mayo Clinic
Rochester, Minnesota, United States
Washington University in St. Louis
St Louis, Missouri, United States
The Mount Sinai Hospital
New York, New York, United States
Columbia University Irving Medical Center
New York, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Oregon Health & Science University
Portland, Oregon, United States
Children's Hospital of Pennsylvania
Philadelphia, Pennsylvania, United States
University of Pennsylvania Health System
Philadelphia, Pennsylvania, United States
Wellspan Health
York, Pennsylvania, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Vanderbilt Heart and Vascular Institute
Nashville, Tennessee, United States
Texas Cardiac Arrhythmia Institute at St. David's Medical Center
Austin, Texas, United States
Houston Methodist Hospital
Houston, Texas, United States
University of Utah Health
Salt Lake City, Utah, United States
University of Virginia Health System
Charlottesville, Virginia, United States
University of Washington Medical Center
Seattle, Washington, United States
The Montreal Heart Institute
Montreal, , Canada
Shaare Zedek Medical Center
Jerusalem, , Israel
Dokkyo Medical University Koshigaya Hospital
Koshigaya, , Japan
Leiden University
Leiden, , Netherlands
Erasmus Medical Center
Rotterdam, , Netherlands
Gregorio Marañón General University Hospital
Madrid, , Spain
St. George's Hospital
Wandsworth, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-001725
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.